SDS

SAFETY DATA SHEET
_______________________________________________________________________________________________________
15. REGULATORY INFORMATION
16. OTHER INFORMATION
Text of CLP/GHS Classification abbreviations mentioned in Section 3
Acute toxicity, oral-Cat.4; H302 - Harmful if swallowed
Sensitization, skin-Cat.1; H317 - May cause an allergic skin reaction
Reproductive toxicity-Cat.2; H361fd - Suspected of damaging fertility. Suspected of damaging the unborn child.
Data Sources:
Safety data sheets for individual ingredients. Pfizer proprietary drug development information.
Reasons for Revision:
Updated Section 2 - Hazard Identification. Updated Section 1 - Identification of the
Substance/Preparation and the Company/Undertaking. Updated Section 3 - Composition /
Information on Ingredients. Updated Section 16 - Other Information.
Revision date:
17-Sep-2015
Prepared by:
Product Stewardship Hazard Communication
Pfizer Global Environment, Health, and Safety Operations
Pfizer Inc believes that the information contained in this Material Safety Data Sheet is accurate, and while it is provided in good faith, it
is without warranty of any kind, expressed or implied. If data for a hazard are not included in this document there is no known
information at this time.
End of Safety Data Sheet
_______________________________________________________________________________________________________
PZ01360
EU EINECS/ELINCS List
234-394-2
Version: 2.2
Page 17 of 17
California Proposition 65
Not Listed
Inventory - United States TSCA - Sect. 8(b)
Present
Revision date: 17-Sep-2015
Australia (AICS):
Present
Material Name: Advil Congestion Relief Tablets